Literature DB >> 26519038

Replication and hematological characterization of human platelet reactivity genetic associations in men from the Caerphilly Prospective Study (CaPS).

John D Eicher1,2, Luting Xue1,3, Yoav Ben-Shlomo4, Andrew D Beswick5, Andrew D Johnson6,7.   

Abstract

Platelet reactivity, an important factor in hemostasis and chronic disease, has widespread inter-individual variability with a substantial genetic contribution. Previously, our group performed a genome-wide association study of platelet reactivity identifying single nucleotide polymorphisms (SNPs) associated with ADP- and epinephrine- induced aggregation, including SNPs in MRVI1, PIK3CG, JMJD1C, and PEAR1, among others. Here, we assessed the association of these previously identified SNPs with ADP-, thrombin-, and shear- induced platelet aggregation. Additionally, we sought to expand the association of these SNPs with blood cell counts and hemostatic factors. To accomplish this, we examined the association of 12 SNPs with seven platelet reactivity and various hematological measures in 1300 middle-aged men in the Caerphilly Prospective Study. Nine of the examined SNPs showed at least suggestive association with platelet reactivity. The strongest associations were with rs12566888 in PEAR1 to ADP-induced (p = 1.51 × 10(-7)) and thrombin-induced (p = 1.91 × 10(-6)) reactivity in platelet rich plasma. Our results indicate PEAR1 functions in a relatively agonist independent manner, possibly through subsequent intracellular propagation of platelet activation. rs10761741 in JMJD1C showed suggestive association with ADP-induced reactivity (p = 1.35 × 10(-3)), but its strongest associations were with platelet-related cell counts (p = 1.30 × 10(-9)). These associations indicate variation in JMJD1C influences pathways that modulate platelet development as well as those that affect reactivity. Associations with other blood cell counts and hemostatic factors were generally weaker among the tested SNPs, indicating a specificity of these SNPs' function to platelets. Future genome-wide analyses will further assess association of these genes and identify new genes important to platelet biology.

Entities:  

Keywords:  Blood platelets; Platelet aggregation; Platelet count; SNPs; Thrombin

Mesh:

Substances:

Year:  2016        PMID: 26519038      PMCID: PMC6504920          DOI: 10.1007/s11239-015-1290-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  36 in total

1.  Whole blood impedance platelet aggregometry and ischemic heart disease. The Caerphilly Collaborative Heart Disease Study.

Authors:  P C Elwood; A D Beswick; D S Sharp; J W Yarnell; S Rogers; S Renaud
Journal:  Arteriosclerosis       Date:  1990 Nov-Dec

2.  The relative power of heat-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease: the Caerphilly and Speedwell studies.

Authors:  P M Sweetnam; J W Yarnell; G D Lowe; I A Baker; J R O'Brien; A Rumley; M D Etherington; P J Whitehead; P C Elwood
Journal:  Br J Haematol       Date:  1998-03       Impact factor: 6.998

3.  Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Authors:  C H Hennekens; M L Dyken; V Fuster
Journal:  Circulation       Date:  1997-10-21       Impact factor: 29.690

4.  Pluripotency transcription factor Oct4 mediates stepwise nucleosome demethylation and depletion.

Authors:  Arvind Shakya; Catherine Callister; Alon Goren; Nir Yosef; Neha Garg; Vahid Khoddami; David Nix; Aviv Regev; Dean Tantin
Journal:  Mol Cell Biol       Date:  2015-01-12       Impact factor: 4.272

5.  Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study.

Authors:  A Rumley; G D Lowe; P M Sweetnam; J W Yarnell; R P Ford
Journal:  Br J Haematol       Date:  1999-04       Impact factor: 6.998

6.  A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways.

Authors:  Chris I Jones; Sarah Bray; Stephen F Garner; Jonathan Stephens; Bernard de Bono; Will G J Angenent; David Bentley; Philippa Burns; Alison Coffey; Panos Deloukas; Mark Earthrowl; Richard W Farndale; Marc F Hoylaerts; Kerstin Koch; Angela Rankin; Catherine M Rice; Jane Rogers; Nilesh J Samani; Michael Steward; Adam Walker; Nicholas A Watkins; Jan-Willem Akkerman; Frank Dudbridge; Alison H Goodall; Willem H Ouwehand
Journal:  Blood       Date:  2009-05-08       Impact factor: 22.113

7.  Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study.

Authors:  P C Elwood; S Renaud; D S Sharp; A D Beswick; J R O'Brien; J W Yarnell
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

8.  PEAR1 attenuates megakaryopoiesis via control of the PI3K/PTEN pathway.

Authors:  Alexandre Kauskot; Christophe Vandenbriele; Sophie Louwette; Rik Gijsbers; Thomas Tousseyn; Kathleen Freson; Peter Verhamme; Marc F Hoylaerts
Journal:  Blood       Date:  2013-05-10       Impact factor: 22.113

9.  Comparative integromics on JMJD1C gene encoding histone demethylase: conserved POU5F1 binding site elucidating mechanism of JMJD1C expression in undifferentiated ES cells and diffuse-type gastric cancer.

Authors:  Masuko Katoh; Masaru Katoh
Journal:  Int J Oncol       Date:  2007-07       Impact factor: 5.650

10.  Targeted deep resequencing identifies coding variants in the PEAR1 gene that play a role in platelet aggregation.

Authors:  Yoonhee Kim; Bhoom Suktitipat; Lisa R Yanek; Nauder Faraday; Alexander F Wilson; Diane M Becker; Lewis C Becker; Rasika A Mathias
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more
  11 in total

1.  Exome-chip meta-analysis identifies association between variation in ANKRD26 and platelet aggregation.

Authors:  Ming-Huei Chen; Lisa R Yanek; Joshua D Backman; John D Eicher; Jennifer E Huffman; Yoav Ben-Shlomo; Andrew D Beswick; Laura M Yerges-Armstrong; Alan R Shuldiner; Jeffrey R O'Connell; Rasika A Mathias; Diane M Becker; Lewis C Becker; Joshua P Lewis; Andrew D Johnson; Nauder Faraday
Journal:  Platelets       Date:  2017-11-29       Impact factor: 3.862

2.  Pairing megakaryopoiesis methylation with PEAR1.

Authors:  Andrew D Johnson
Journal:  Blood       Date:  2016-08-18       Impact factor: 22.113

3.  A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor Signaling.

Authors:  Benjamin A T Rodriguez; Arunoday Bhan; Andrew Beswick; Peter C Elwood; Teemu J Niiranen; Veikko Salomaa; David-Alexandre Trégouët; Pierre-Emmanuel Morange; Mete Civelek; Yoav Ben-Shlomo; Thorsten Schlaeger; Ming-Huei Chen; Andrew D Johnson
Journal:  Am J Hum Genet       Date:  2020-07-09       Impact factor: 11.025

4.  Prospective Evaluation of Genetic Variation in Platelet Endothelial Aggregation Receptor 1 Reveals Aspirin-Dependent Effects on Platelet Aggregation Pathways.

Authors:  J D Backman; L M Yerges-Armstrong; R B Horenstein; S Newcomer; S Shaub; M Morrisey; P Donnelly; M Drolet; K Tanner; M A Pavlovich; J R O'Connell; B D Mitchell; J P Lewis
Journal:  Clin Transl Sci       Date:  2017-01-11       Impact factor: 4.689

5.  Platelet responses to agonists in a cohort of highly characterised platelet donors are consistent over time.

Authors:  S F Garner; A Furnell; B C Kahan; C I Jones; A Attwood; P Harrison; A M Kelly; A H Goodall; R Cardigan; W H Ouwehand
Journal:  Vox Sang       Date:  2016-12-21       Impact factor: 2.144

6.  Polymorphisms in GP6, PEAR1A, MRVI1, PIK3CG, JMJD1C, and SHH Genes in Patients with Unstable Angina.

Authors:  Rafał Rudzik; Violetta Dziedziejko; Monika Ewa Rać; Marek Sawczuk; Agnieszka Maciejewska-Skrendo; Krzysztof Safranow; Andrzej Pawlik
Journal:  Int J Environ Res Public Health       Date:  2020-10-15       Impact factor: 3.390

7.  Genome sequencing unveils a regulatory landscape of platelet reactivity.

Authors:  Ali R Keramati; Ming-Huei Chen; Benjamin A T Rodriguez; Lisa R Yanek; Arunoday Bhan; Brady J Gaynor; Kathleen Ryan; Jennifer A Brody; Xue Zhong; Qiang Wei; Kai Kammers; Kanika Kanchan; Kruthika Iyer; Madeline H Kowalski; Achilleas N Pitsillides; L Adrienne Cupples; Bingshan Li; Thorsten M Schlaeger; Alan R Shuldiner; Jeffrey R O'Connell; Ingo Ruczinski; Braxton D Mitchell; Nauder Faraday; Margaret A Taub; Lewis C Becker; Joshua P Lewis; Rasika A Mathias; Andrew D Johnson
Journal:  Nat Commun       Date:  2021-06-15       Impact factor: 14.919

8.  Variants of PEAR1 Are Associated With Outcome in Patients With ACS and Stable CAD Undergoing PCI.

Authors:  Fabian Stimpfle; Maike Bauer; Dominik Rath; Elke Schaeffeler; Matthias Schwab; Meinrad Gawaz; Stefan Winter; Tobias Geisler
Journal:  Front Pharmacol       Date:  2018-05-15       Impact factor: 5.810

9.  Variation of PEAR1 DNA methylation influences platelet and leukocyte function.

Authors:  Benedetta Izzi; Francesco Gianfagna; Wen-Yi Yang; Katrien Cludts; Amalia De Curtis; Peter Verhamme; Augusto Di Castelnuovo; Chiara Cerletti; Maria Benedetta Donati; Giovanni de Gaetano; Jan A Staessen; Marc F Hoylaerts; Licia Iacoviello
Journal:  Clin Epigenetics       Date:  2019-10-29       Impact factor: 6.551

10.  Platelet-Related Variants Identified by Exomechip Meta-analysis in 157,293 Individuals.

Authors:  John D Eicher; Nathalie Chami; Tim Kacprowski; Akihiro Nomura; Ming-Huei Chen; Lisa R Yanek; Salman M Tajuddin; Ursula M Schick; Andrew J Slater; Nathan Pankratz; Linda Polfus; Claudia Schurmann; Ayush Giri; Jennifer A Brody; Leslie A Lange; Ani Manichaikul; W David Hill; Raha Pazoki; Paul Elliot; Evangelos Evangelou; Ioanna Tzoulaki; He Gao; Anne-Claire Vergnaud; Rasika A Mathias; Diane M Becker; Lewis C Becker; Amber Burt; David R Crosslin; Leo-Pekka Lyytikäinen; Kjell Nikus; Jussi Hernesniemi; Mika Kähönen; Emma Raitoharju; Nina Mononen; Olli T Raitakari; Terho Lehtimäki; Mary Cushman; Neil A Zakai; Deborah A Nickerson; Laura M Raffield; Rakale Quarells; Cristen J Willer; Gina M Peloso; Goncalo R Abecasis; Dajiang J Liu; Panos Deloukas; Nilesh J Samani; Heribert Schunkert; Jeanette Erdmann; Myriam Fornage; Melissa Richard; Jean-Claude Tardif; John D Rioux; Marie-Pierre Dube; Simon de Denus; Yingchang Lu; Erwin P Bottinger; Ruth J F Loos; Albert Vernon Smith; Tamara B Harris; Lenore J Launer; Vilmundur Gudnason; Digna R Velez Edwards; Eric S Torstenson; Yongmei Liu; Russell P Tracy; Jerome I Rotter; Stephen S Rich; Heather M Highland; Eric Boerwinkle; Jin Li; Ethan Lange; James G Wilson; Evelin Mihailov; Reedik Mägi; Joel Hirschhorn; Andres Metspalu; Tõnu Esko; Caterina Vacchi-Suzzi; Mike A Nalls; Alan B Zonderman; Michele K Evans; Gunnar Engström; Marju Orho-Melander; Olle Melander; Michelle L O'Donoghue; Dawn M Waterworth; Lars Wallentin; Harvey D White; James S Floyd; Traci M Bartz; Kenneth M Rice; Bruce M Psaty; J M Starr; David C M Liewald; Caroline Hayward; Ian J Deary; Andreas Greinacher; Uwe Völker; Thomas Thiele; Henry Völzke; Frank J A van Rooij; André G Uitterlinden; Oscar H Franco; Abbas Dehghan; Todd L Edwards; Santhi K Ganesh; Sekar Kathiresan; Nauder Faraday; Paul L Auer; Alex P Reiner; Guillaume Lettre; Andrew D Johnson
Journal:  Am J Hum Genet       Date:  2016-06-23       Impact factor: 11.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.